[Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
D000721:Ancrod / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000628:therapy*; D001241:Aspirin / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000188:drug therapy; D003911:Dextrans / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004106:Dilatation; D004176:Dipyridamole / Q000627:therapeutic use; D005081:Exercise Therapy; D005734:Gangrene / Q000628:therapy; D006438:Hemodilution; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007261:Infusions, Intra-Arterial; D007263:Infusions, Parenteral; D007383:Intermittent Claudication / Q000628:therapy; D008901:Mineralocorticoids / Q000627:therapeutic use; D009042:Motivation; D009257:Nafronyl / Q000627:therapeutic use; D010431:Pentoxifylline / Q000627:therapeutic use; D012306:Risk; D013300:Streptokinase / Q000627:therapeutic use
D000925:Anticoagulants; D003911:Dextrans; D004071:Digitalis Glycosides; D008901:Mineralocorticoids; D009257:Nafronyl; D004176:Dipyridamole; D013300:Streptokinase; D000721:Ancrod; D001241:Aspirin; D010431:Pentoxifylline
Periphere arterielle Durchblutungs-störungen. Prinzipien, Möglichkeiten und Grenzen der konservativen Therapie.